Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 23, 2010, Pages 10424-10429

  Robertson, Amy L ^a   Headey, Stephen J ^b   Saunders, Helen M ^a   Ecroyd, Heath ^c   Scanlon, Martin J ^b   Carver, John A ^d   Bottomley, Stephen P ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

crystallin; Fibrillogenesis

Indexed keywords

ALPHA CRYSTALLIN; ATAXIN 3;

AMINO TERMINAL SEQUENCE; ARTICLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN INTERACTION;

ALPHA-CRYSTALLIN B CHAIN; HEAT-SHOCK PROTEINS, SMALL; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SOLUBILITY;

EID: 77953799932     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914773107     Document Type: Article

References (52)

1. Haslbeck M, Franzmann T, Weinfurtner D, Buchner J (2005) Some like it hot: The structure and function of small heat-shock proteins. Nat Struct Mol Biol 12(10):842-846. (Pubitemid 41486706)
2. Ecroyd H, Carver JA (2009) Crystallin proteins and amyloid fibrils. Cell Mol Life Sci 66(1):62-81.
3. Horwitz J (2003) Alpha-crystallin. Exp Eye Res 76(2):145-153.
4. Iwaki T, et al. (1992) Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol 140(2):345-356.
5. Das KP, Surewicz WK (1995) Temperature-induced exposure of hydrophobic surfaces and its effect on the chaperone activity of alpha-crystallin. FEBS Lett 369(2-3):321-325.
6. Rekas A, Jankova L, Thorn DC, Cappai R, Carver JA (2007) Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species. FEBS J 274(24):6290-6304.
7. Lowe J, et al. (1992) alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 166(1):61-68.
8. Renkawek K, et al. (1992) alpha B-crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol 83(3):324-327.
9. Bilen J, Bonini NM (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 3(10):1950-1964. (Pubitemid 350072059)
10. Wilhelmus MM, et al. (2006) Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res 1089(1):67-78. (Pubitemid 43786300)
11. Hatters DM, Lindner RA, Carver JA, Howlett GJ (2001) The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II. J Biol Chem 276(36):33755-33761. (Pubitemid 37384595)
12. Carver JA, et al. (2002) The interaction of the molecular chaperone alpha-crystallin with unfolding alpha-lactalbumin: A structural and kinetic spectroscopic study. J Mol Biol 318(3):815-827.
13. Devlin GL, Carver JA, Bottomley SP (2003) The selective inhibition of serpin aggregation by the molecular chaperone, alpha-crystallin, indicates a nucleation-dependent specificity. J Biol Chem 278(49):48644-48650.
14. Raman B, et al. (2005) AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin. Biochem J 392(Pt 3):573-581.
15. Ecroyd H, et al. (2007) Mimicking phosphorylation of alphaB-crystallin affects its chaperone activity. Biochem J 401(1):129-141. (Pubitemid 46114607)
16. Chen S, Ferrone FA, Wetzel R (2002) Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci USA 99(18):11884-11889.
17. Ignatova Z, Gierasch LM (2006) Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent beta barrel protein. J Biol Chem 281(18):12959-12967.
18. Ellisdon AM, Pearce MC, Bottomley SP (2007) Mechanisms of ataxin-3 misfolding and fibril formation: Kinetic analysis of a disease-associated polyglutamine protein. J Mol Biol 368(2):595-605.
19. Ellisdon AM, Thomas B, Bottomley SP (2006) The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J Biol Chem 281(25):16888-16896.
20. Thakur AK, et al. (2009) Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16(4):380-389.
21. Bulone D, Masino L, Thomas DJ, San Biagio PL, Pastore A (2006) The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils. PLoS ONE 1:e111.
22. de Chiara C, et al. (2005) The AXH domain adopts alternative folds the solution structure of HBP1 AXH. Structure 13(5):743-753.
23. Wyttenbach A, et al. (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 11(9):1137-1151.
24. Carra S, Brunsting JF, Lambert H, Landry J, Kampinga HH (2009) HspB8 participates in protein quality control by a non-chaperone-like mechanism that requires eIF2{alpha} phosphorylation. J Biol Chem 284(9):5523-5532.
25. Carra S, Sivilotti M, Chavez Zobel AT, Lambert H, Landry J (2005) HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet 14(12):1659-1669. (Pubitemid 40895518)
26. Robertson AL, et al. (2008) The structural impact of a polyglutamine tract is location-dependent. Biophys J 95(12):5922-5930.
27. Rekas A, et al. (2004) Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: Effects on amyloid fibril formation and chaperone activity. J Mol Biol 340(5):1167-1183.
28. Muchowski PJ, et al. (2000) Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA 97(14):7841-7846.
29. Scherzinger E, et al. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90(3):549-558. (Pubitemid 27347244)
30. Masino L, et al. (2004) Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J Mol Biol 344(4):1021-1035. (Pubitemid 39491247)
31. Liepinsh E, et al. (2001) Thioredoxin fold as homodimerization module in the putative chaperone ERp29: NMR structures of the domains and experimental model of the 51 kDa dimer. Structure 9(6):457-471. (Pubitemid 32575344)
32. Pintacuda G, Otting G (2002) Identification of protein surfaces by NMR measurements with a pramagnetic Gd(III) chelate. J Am Chem Soc 124(3):372-373.
33. Dougan L, Li J, Badilla CL, Berne BJ, Fernandez JM (2009) Single homopolypeptide chains collapse into mechanically rigid conformations. Proc Natl Acad Sci USA 106(31):12605-12610.
34. Crick SL, Jayaraman M, Frieden C, Wetzel R, Pappu RV (2006) Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions. Proc Natl Acad Sci USA 103(45):16764-16769.
35. Klein FA, et al. (2007) Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: Towards a length-dependent toxicity gradient. J Mol Biol 371(1):235-244.
36. Behrends C, et al. (2006) Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol Cell 23(6):887-897.
37. Nozaki K, Onodera O, Takano H, Tsuji S (2001) Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation. Neuroreport 12(15):3357-3364.
38. Duennwald ML, Jagadish S, Muchowski PJ, Lindquist S (2006) Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl Acad Sci USA 103(29):11045-11050. (Pubitemid 44148415)
39. Branco J, et al. (2008) Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet 17(3):376-390.
40. Tam S, et al. (2009) The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat Struct Mol Biol 16(12):1279-1285.
41. Chow MK, Mackay JP, Whisstock JC, Scanlon MJ, Bottomley SP (2004) Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem Biophys Res Commun 322(2):387-394.
42. Lindner RA, Kapur A, Mariani M, Titmuss SJ, Carver JA (1998) Structural alterations of alpha-crystallin during its chaperone action. Eur J Biochem 258(1):170-183. (Pubitemid 28538323)
43. Lindner RA, Kapur A, Carver JA (1997) The interaction of the molecular chaperone, alpha-crystallin, with molten globule states of bovine alpha-lactalbumin. J Biol Chem 272(44):27722-27729. (Pubitemid 27473569)
44. Chan HY, Warrick JM, Gray-Board GL, Paulson HL, Bonini NM (2000) Mechanisms of chaperone suppression of polyglutamine disease: Selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet 9(19):2811-2820.
45. Nicastro G, Habeck M, Masino L, Svergun DI, Pastore A (2006) Structure validation of the Josephin domain of ataxin-3: Conclusive evidence for an open conformation. J Biomol NMR 36(4):267-277.
46. Nicastro G, et al. (2009) Josephin domain of ataxin-3 contains two distinct ubiquitin binding sites. Biopolymers 91(12):1204-1214.
47. Nicastro G, et al. (2005) The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc Natl Acad Sci USA 102(30):10493-10498.
48. Plater ML, Goode D, Crabbe MJ (1996) Effects of site-directed mutations on the chaperone-like activity of alphaB-crystallin. J Biol Chem 271(45):28558-28566.
49. Aquilina JA, Watt SJ (2007) The N-terminal domain of alphaB-crystallin is protected from proteolysis by bound substrate. Biochem Biophys Res Commun 353(4):1115-1120.
50. Jaya N, Garcia V, Vierling E (2009) Substrate binding site flexibility of the small heat shock protein molecular chaperones. Proc Natl Acad Sci USA 106(37):15604-15609.
51. Chow MK, Ellisdon AM, Cabrita LD, Bottomley SP (2004) Polyglutamine expansion in ataxin-3 does not affect protein stability: Implications formisfolding and disease. J Biol Chem 279(46):47643-47651.
52. Horwitz J, Huang QL, Ding L, Bova MP (1998) Lens alpha-crystallin: Chaperone-like properties. Methods Enzymol 290:365-383.